The “Flying Pharmacist” brings diabetes education to Manitoba's North Prescriptions for change Better treatments cut heart disease mortality Favourable risk factor trends and improvements in therapy each explain about half the substantial decrease in coronary heart disease (CHD) mortality that has occurred in Ontario in recent years. Long-term kidney risk follows preeclampsia Microalbuminuria more likely to occur than in women with uncomplicated pregnancy Low-dose combo therapy fends off diabetes Canadian trial of rosiglitazone-metformin pill not powered for adverse cardiovascular events First-in-class medications target RA and type 2 diabetes 2010 Canadian hypertension guidelines now available Nokia offers free healthcare apps Six tips for getting the most out of laboratory tests Improving communication between your office and your lab results in greater efficiency and better care for your patient Canadian researchers disagree on halting rosiglitazone trial Canadian researchers disagree on halting trial of diabetes drug rosiglitazone First Previous 201 202 203 204 205 Next Last
